Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Prion disease induced alterations in gene expression in spleen and brain prior to clinical symptoms.

Kim HO, Snyder GP, Blazey TM, Race RE, Chesebro B, Skinner PJ.

Adv Appl Bioinform Chem. 2008;1:29-50. Epub 2008 Sep 7.

2.

Levels of abnormal prion protein in deer and elk with chronic wasting disease.

Race BL, Meade-White KD, Ward A, Jewell J, Miller MW, Williams ES, Chesebro B, Race RE.

Emerg Infect Dis. 2007 Jun;13(6):824-30.

3.

Transmission and adaptation of chronic wasting disease to hamsters and transgenic mice: evidence for strains.

Raymond GJ, Raymond LD, Meade-White KD, Hughson AG, Favara C, Gardner D, Williams ES, Miller MW, Race RE, Caughey B.

J Virol. 2007 Apr;81(8):4305-14. Epub 2007 Feb 7.

4.

Enhanced antiscrapie effect using combination drug treatment.

Kocisko DA, Caughey B, Morrey JD, Race RE.

Antimicrob Agents Chemother. 2006 Oct;50(10):3447-9.

5.

Prion-induced amyloid heart disease with high blood infectivity in transgenic mice.

Trifilo MJ, Yajima T, Gu Y, Dalton N, Peterson KL, Race RE, Meade-White K, Portis JL, Masliah E, Knowlton KU, Chesebro B, Oldstone MB.

Science. 2006 Jul 7;313(5783):94-7.

6.

Gene expression alterations in brains of mice infected with three strains of scrapie.

Skinner PJ, Abbassi H, Chesebro B, Race RE, Reilly C, Haase AT.

BMC Genomics. 2006 May 16;7:114.

7.

Potent antiscrapie activities of degenerate phosphorothioate oligonucleotides.

Kocisko DA, Vaillant A, Lee KS, Arnold KM, Bertholet N, Race RE, Olsen EA, Juteau JM, Caughey B.

Antimicrob Agents Chemother. 2006 Mar;50(3):1034-44.

8.

A porphyrin increases survival time of mice after intracerebral prion infection.

Kocisko DA, Caughey WS, Race RE, Roper G, Caughey B, Morrey JD.

Antimicrob Agents Chemother. 2006 Feb;50(2):759-61.

9.

The most infectious prion protein particles.

Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, Caughey B.

Nature. 2005 Sep 8;437(7056):257-61.

10.

Evaluation of new cell culture inhibitors of protease-resistant prion protein against scrapie infection in mice.

Kocisko DA, Morrey JD, Race RE, Chen J, Caughey B.

J Gen Virol. 2004 Aug;85(Pt 8):2479-83.

PMID:
15269390
11.

Scrapie-specific neuronal lesions are independent of neuronal PrP expression.

Jeffrey M, Goodsir CM, Race RE, Chesebro B.

Ann Neurol. 2004 Jun;55(6):781-92.

PMID:
15174012
12.
13.
14.

Serological evidence for an inflammatory response in murine scrapie.

Coe JE, Race RE, Ross MJ.

J Infect Dis. 2001 Jan 15;183(2):185-191. Epub 2000 Dec 15.

PMID:
11120924
15.

Methods for studying prion protein (PrP) metabolism and the formation of protease-resistant PrP in cell culture and cell-free systems. An update.

Caughey B, Raymond GJ, Priola SA, Kocisko DA, Race RE, Bessen RA, Lansbury PT Jr, Chesebro B.

Mol Biotechnol. 1999 Nov;13(1):45-55.

PMID:
10934521
16.

The trouble with transmissible degenerative encephalopathy agents.

Race RE.

Vet J. 2000 Jan;159(1):3-4. No abstract available.

PMID:
10640405
17.

Astrocyte-specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie.

Raeber AJ, Race RE, Brandner S, Priola SA, Sailer A, Bessen RA, Mucke L, Manson J, Aguzzi A, Oldstone MB, Weissmann C, Chesebro B.

EMBO J. 1997 Oct 15;16(20):6057-65.

18.

Neuron-specific expression of a hamster prion protein minigene in transgenic mice induces susceptibility to hamster scrapie agent.

Race RE, Priola SA, Bessen RA, Ernst D, Dockter J, Rall GF, Mucke L, Chesebro B, Oldstone MB.

Neuron. 1995 Nov;15(5):1183-91.

19.

Severe autolysis does not prevent scrapie diagnosis in sheep.

Race RE, Ernst D, Sutton D.

J Vet Diagn Invest. 1994 Oct;6(4):486-9. No abstract available.

PMID:
7858030
20.
21.

Detection of prion protein in formalin-fixed brain by hydrated autoclaving immunohistochemistry for the diagnosis of scrapie in sheep.

Miller JM, Jenny AL, Taylor WD, Race RE, Ernst DR, Katz JB, Rubenstein R.

J Vet Diagn Invest. 1994 Jul;6(3):366-8. No abstract available.

PMID:
7948209
22.
23.

Intracerebral transmission of scrapie to cattle.

Cutlip RC, Miller JM, Race RE, Jenny AL, Katz JB, Lehmkuhl HD, DeBey BM, Robinson MM.

J Infect Dis. 1994 Apr;169(4):814-20.

PMID:
8133096
24.

Congo red inhibition of scrapie agent replication.

Caughey B, Ernst D, Race RE.

J Virol. 1993 Oct;67(10):6270-2.

25.

Immunohistochemical detection of prion protein in sheep with scrapie.

Miller JM, Jenny AL, Taylor WD, Marsh RF, Rubenstein R, Race RE.

J Vet Diagn Invest. 1993 Jul;5(3):309-16.

PMID:
8104039
26.

Comparative analysis of scrapie agent inactivation methods.

Ernst DR, Race RE.

J Virol Methods. 1993 Feb;41(2):193-201.

PMID:
8496294
27.

Immunization of dogs with Q fever vaccines: comparison of phase I, II and phase I CMR Coxiella burnetii vaccines.

Williams JC, Peacock MG, Race RE.

Rev Elev Med Vet Pays Trop. 1993;46(1-2):87-94.

PMID:
8134661
28.
29.

Demonstration of scrapie strain diversity in infected PC12 cells.

Rubenstein R, Deng H, Race RE, Ju W, Scalici CL, Papini MC, Kascsak RJ, Carp RI.

J Gen Virol. 1992 Nov;73 ( Pt 11):3027-31.

PMID:
1359002
30.

Potent inhibition of scrapie-associated PrP accumulation by congo red.

Caughey B, Race RE.

J Neurochem. 1992 Aug;59(2):768-71.

PMID:
1352803
32.

Protease sensitivity and nuclease resistance of the scrapie agent propagated in vitro in neuroblastoma cells.

Neary K, Caughey B, Ernst D, Race RE, Chesebro B.

J Virol. 1991 Feb;65(2):1031-4.

33.

Impaired phagocytosis by the mononuclear phagocytic system in sapphire mink affected with Aleutian disease.

Lodmell DL, Bergman RK, Bloom ME, Ewalt LC, Hadlow WJ, Race RE.

Proc Soc Exp Biol Med. 1990 Oct;195(1):75-8.

PMID:
2399264
34.
35.

Analysis of linkage between scrapie incubation period and the prion protein gene in mice.

Race RE, Graham K, Ernst D, Caughey B, Chesebro B.

J Gen Virol. 1990 Feb;71 ( Pt 2):493-7.

PMID:
1968507
36.

Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells.

Caughey B, Race RE, Ernst D, Buchmeier MJ, Chesebro B.

J Virol. 1989 Jan;63(1):175-81.

37.

Passive transfer of antiviral antibodies restricts replication of Aleutian mink disease parvovirus in vivo.

Alexandersen S, Larsen S, Cohn A, Uttenthal A, Race RE, Aasted B, Hansen M, Bloom ME.

J Virol. 1989 Jan;63(1):9-17.

38.
39.

In vitro expression in eukaryotic cells of a prion protein gene cloned from scrapie-infected mouse brain.

Caughey B, Race RE, Vogel M, Buchmeier MJ, Chesebro B.

Proc Natl Acad Sci U S A. 1988 Jul;85(13):4657-61.

40.

Detection of prion protein mRNA in normal and scrapie-infected tissues and cell lines.

Caughey B, Race RE, Chesebro B.

J Gen Virol. 1988 Mar;69 ( Pt 3):711-6.

PMID:
2895163
41.
43.

Characterization of scrapie infection in mouse neuroblastoma cells.

Race RE, Fadness LH, Chesebro B.

J Gen Virol. 1987 May;68 ( Pt 5):1391-9.

PMID:
3106566
44.

Experimental infection of sheep and goats with transmissible mink encephalopathy virus.

Hadlow WJ, Race RE, Kennedy RC.

Can J Vet Res. 1987 Jan;51(1):135-44.

45.

Analysis of Aleutian disease of mink parvovirus infection using strand-specific hybridization probes.

Bloom ME, Race RE, Wolfinbarger JB.

Intervirology. 1987;27(2):102-11.

PMID:
2444554
46.

Cerebrocortical degeneration in goats inoculated with mink-passaged scrapie virus.

Hadlow WJ, Race RE.

Vet Pathol. 1986 Sep;23(5):543-9.

PMID:
2946103
48.
49.
50.

Experimental infection of fetal and newborn Suffolk sheep with scrapie virus.

Hadlow WJ, Jackson TA, Race RE.

Am J Vet Res. 1984 Dec;45(12):2637-9.

PMID:
6441491

Supplemental Content

Support Center